BNP Paribas Financial Markets’s Agile Therapeutics AGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1
Closed -$13 4870
2022
Q3
$13 Buy
+1
New +$25 ﹤0.01% 4704
2022
Q2
Sell
-1
Closed -$379 4306
2022
Q1
$379 Hold
1
﹤0.01% 4045
2021
Q4
$903 Hold
1
﹤0.01% 4060
2021
Q3
$1.85K Hold
1
﹤0.01% 3810
2021
Q2
$2.57K Sell
1
-3
-75% -$9.89K ﹤0.01% 3856
2021
Q1
$17.9K Sell
4
-3
-43% -$16.2K ﹤0.01% 3775
2020
Q4
$40.9K Sell
7
-2
-22% -$11.8K ﹤0.01% 3643
2020
Q3
$55.1K Buy
9
+8
+800% +$45.9K ﹤0.01% 3426
2020
Q2
$7.08K Buy
+1
New +$5.2K ﹤0.01% 3862
2020
Q1
Hold
0
4308
2019
Q4
Hold
0
4414
2019
Q3
Hold
0
4495
2019
Q2
Hold
0
4517
2019
Q1
Hold
0
4263
2018
Q4
Hold
0
4049
2018
Q3
Hold
0
4373
2018
Q2
Hold
0
4342
2018
Q1
Hold
0
4105
2017
Q4
Hold
0
4091
2017
Q3
Hold
0
4051
2017
Q2
Hold
0
4088
2017
Q1
Hold
0
3571
2016
Q4
Hold
0
4085
2016
Q3
Hold
0
3372
2016
Q2
Hold
0
3408
2016
Q1
Sell
-1
Closed -$18.4K 3186
2015
Q4
$18.4K Hold
1
﹤0.01% 3308
2015
Q3
$13.9K Buy
+1
New +$17.8K ﹤0.01% 3384
2015
Q2
Hold
0
3389

Other funds holding AGRX

BNP Paribas Financial Markets's AGRX Position: Q4 2022 in Review

BNP Paribas Financial Markets sold out of Agile Therapeutics (AGRX) in Q4 2022, closing a stake of 1 share — an estimated $13 sold.

BNP Paribas Financial Markets first reported a position in AGRX in Q3 2015 and held it in 11 quarters. The position peaked at $55.1K in Q3 2020. 26 funds tracked by Wall St. Rank hold AGRX as of Q4 2022.

  • BNP Paribas Financial Markets reported no remaining Agile Therapeutics position as of Q4 2022 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 1 Agile Therapeutics share in Q4 2022, an estimated $13.
  • BNP Paribas Financial Markets first reported a position in Agile Therapeutics in Q3 2015 and held it in 11 quarters.
  • BNP Paribas Financial Markets's Agile Therapeutics position peaked at $55.1K in Q3 2020.
  • 26 funds tracked by Wall St. Rank held Agile Therapeutics as of Q4 2022.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2022, filed 14 Feb 2023.